BOXABL
BXBL
3.25
-0.03
-0.91%
BOXABL
US · BXBL
#3423 by market cap
Listed 2025
3.25
-0.03
-0.91%
Live - 5344 symbols - heartbeat 208s ago
· 2026-10-08 09:56
Pre-market
3.26
-0.61%
After-hours
3.17
-3.35%
- Market cap
- 784.85M
- P/E (TTM)i
- -13.54
- P/Bi
- 8.95
- EPSi
- -0.24
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on BXBL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 13.06, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year -55.15% YoY
Margins
- Gross margin
- -1,043.59%
- Operating margin
- -3,910.17%
- Net margin
- -3,801.12%
Key ratios & quality
- Altman Z-Scorei
- 13.06
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.96M | 10.87M | 344.00K | 3.38M | 1.51M |
| Gross profit | -3.36M | -12.80M | -10.21M | -11.59M | -15.80M |
| Selling & admin expenses | 6.27M | 16.91M | 23.26M | 22.11M | 40.10M |
| Research & development | 2.63M | 3.38M | 8.29M | 6.59M | 3.30M |
| Operating profit | -12.26M | -33.09M | -41.76M | -40.29M | -59.20M |
| Pretax profit | -13.58M | -610.75M | -39.53M | -50.95M | -57.55M |
| Tax | -- | -- | -- | -- | -- |
| Net profit | -13.58M | -610.75M | -39.53M | -50.95M | -57.55M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.00 | -0.20 | -0.01 | -0.02 | -0.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 123.00K | 279.00K | 186.00K | 926.00K | 1.56M | 495.00K |
| Gross profit | -2.00M | -9.44M | -1.75M | -2.61M | -3.35M | -3.86M |
| Selling & admin expenses | 8.16M | 21.08M | 7.72M | 3.15M | 3.71M | 5.52M |
| Research & development | 583.00K | 676.00K | 1.80M | 242.00K | 566.00K | 274.00K |
| Operating profit | -10.74M | -31.20M | -11.26M | -6.01M | -7.63M | -9.65M |
| Pretax profit | -10.26M | -30.80M | -10.78M | -5.70M | -7.58M | -9.60M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -10.26M | -30.80M | -10.78M | -5.70M | -7.58M | -9.60M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 28.32M | 92.16M | 65.66M | 49.33M | 48.86M |
| Cash & ST investments | 21.42M | 83.41M | 46.26M | 21.70M | 29.02M |
| Inventory | 4.92M | 8.24M | 18.69M | 24.26M | 18.85M |
| Total assets | 39.21M | 110.08M | 107.53M | 75.05M | 69.26M |
| Total current liabilities | 9.86M | 9.17M | 14.52M | 12.44M | 11.59M |
| Short-term debt | 938.93K | 1.00M | 3.18M | 3.49M | 3.52M |
| Long-term debt | 30.93M | -- | -- | -- | -- |
| Total liabilities | 46,011,176.00 | 12,262,715.00 | 25,178,000.00 | 19,612,000.00 | 15,242,000.00 |
| Total equity | -6.80M | 97.82M | 82.35M | 55.44M | 54.02M |
| Retained earnings | -15.57M | -626.31M | -667.49M | -718.44M | -775.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 57.06M | 55.70M | 48.86M | 42.79M | 34.44M |
| Cash & ST investments | -- | 16.80M | 36.20M | 29.02M | 22.26M | 14.69M |
| Inventory | -- | 16.52M | 17.47M | 18.85M | 18.18M | 17.87M |
| Total assets | -- | 81.26M | 77.73M | 69.26M | 61.66M | 51.72M |
| Total current liabilities | -- | 12.83M | 13.55M | 11.59M | 11.97M | 11.28M |
| Short-term debt | -- | 3.66M | 3.74M | 3.52M | 3.30M | 2.93M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | 18,128,000.00 | 17,872,000.00 | 15,242,000.00 | 14,920,000.00 | 13,641,000.00 |
| Total equity | -- | 63.13M | 59.85M | 54.02M | 46.74M | 38.08M |
| Retained earnings | -- | -759.50M | -770.28M | -775.98M | -783.56M | -793.17M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -11.40M | -33.28M | -35.62M | -38.40M | -47.18M |
| Depreciation & amortization | 265.37K | 1.20M | 2.38M | 1.05M | 585.00K |
| Free cash flow | -16.78M | -40.27M | -48.03M | -40.79M | -47.36M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- |
| Ending cash balance | 21.42M | 9.02M | 22.33M | 9.63M | 32.99M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -14.79M | -21.20M | -6.05M | -5.15M | -7.10M | -8.77M |
| Depreciation & amortization | 466.00K | 467.00K | 452.00K | -800.00K | 327.00K | 215.00K |
| Free cash flow | -14.90M | -21.20M | -6.09M | -5.17M | -7.29M | -8.78M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 15.29M | 18.70M | 38.45M | 32.99M | 26.24M | 18.69M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- |
| ROA %i | -34.64 | -818.18 | -36.33 | -56.53 | -81.06 |
| ROIC %i | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -626.81 | -5,611.45 | -12,139.53 | -1,193.42 | -3,910.17 |
| FCF / sales %i | -- | -- | -- | -- | -- |
| Current ratioi | 2.87 | 10.05 | 4.52 | 3.96 | 4.21 |
| Quick ratioi | 2.22 | 9.09 | 3.20 | 1.99 | 2.52 |
| Debt / assetsi | 91.69 | 3.72 | 12.87 | 14.21 | 10.35 |
| LT debt / equityi | -- | -- | -- | -- | -- |
| Interest coveragei | -9.25 | -669.68 | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 19.96 | -48.16 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -- | -71.53 | -77.03 | -81.06 | -88.98 | -50.64 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -1,934.56 | -2,549.96 | -3,910.17 | -1,903.56 | -1,092.22 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | -- | 4.45 | 4.11 | 4.21 | 3.57 | 3.05 |
| Quick ratioi | -- | 3.02 | 2.73 | 2.52 | 1.97 | 1.33 |
| Debt / assetsi | -- | 11.02 | 10.38 | 10.35 | 10.13 | 10.25 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 09:56:48 · For reference only, not investment advice and not tailored to your situation.